<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263012</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00017; ch19Grapow2</org_study_id>
    <nct_id>NCT04263012</nct_id>
  </id_info>
  <brief_title>Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital</brief_title>
  <official_title>Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital: 5 Year Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to demonstrate the challenges and the effort to set up an
      artificial heart program as well as to report about the follow-up treatment and the mortality
      rate
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>30 days mortality</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>mortality rate 30 days after receiving the LVAD implant</description>
  </primary_outcome>
  <primary_outcome>
    <measure>rehospitalization rate</measure>
    <time_frame>between day of surgery and 31.12.2019</time_frame>
    <description>rehospitalization rate of patients after receiving the LVAD implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>survival rate</measure>
    <time_frame>between day of surgery and 31.12.2019</time_frame>
    <description>survival rate of patients after receiving the LVAD implant (Kaplan-Meier curve)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Heart Implant Complication</condition>
  <arm_group>
    <arm_group_label>Patients with an implanted LVAD</arm_group_label>
    <description>Patients which received an implantation of a left ventricular assist device (LVAD) at the University Hospital Basel since 2014</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of patient data</intervention_name>
    <description>assess mortality rate, rehospitalization and survival rate of patients after receiving an artificial heart implant</description>
    <arm_group_label>Patients with an implanted LVAD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who received an LVAD implant
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who received an LVAD implant

        Exclusion Criteria:

          -  not enough data collected

          -  stated will of the Patient, that his data can not be used
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Martin Grapow, Prof Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzzentrum Hirslanden ZÃ¼rich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herzchirurgie University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 6, 2020</study_first_submitted>
  <study_first_submitted_qc>February 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>left ventricular assist device (LVAD)</keyword>
  <keyword>heart</keyword>
  <keyword>implant</keyword>
  <keyword>artificial</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

